Potential of cationic porphyrins for photodynamic treatment of cutaneous Leishmaniasis

Photodiagnosis and Photodynamic Therapy

Volumn 3, Issue 3, 2006, Pages 162-167

  Bristow, Carrie Anne ^a   Hudson, Robert ^a   Paget, Timothy A ^b   Boyle, Ross W ^a  

^a Department of Chemistry   (United Kingdom)

^b MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

Leishmaniasis; Photodynamic therapy; Porphyrins

Indexed keywords

PORPHYRIN DERIVATIVE; TETRAKIS(4 N,N,N,N TRIMETHYLANILINIUM)PORPHYRIN TETRACHLORIDE; TETRAKIS(N METHYL 4 PYRIDYL)PORPHYRIN TETRATOSYLATE; TETRAKIS[4 (DICYCLOHEXYLPHENYLPHOPHONIUM YLMETHYL)PHENYL]PORPHYRIN TETRABROMIDE; TETRAKIS[4 (TRIBUTYLPHOSPHONIUM YLMETHYL)PHENYL]PORPHYRIN TETRABROMIDE; UNCLASSIFIED DRUG;

ARTICLE; CYTOTOXICITY; KERATINOCYTE; LEISHMANIA MAJOR; MACROPHAGE; MAMMAL CELL; MICROORGANISM; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS;

LEISHMANIA MAJOR; MAMMALIA;

EID: 33746504537     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2006.04.004     Document Type: Article

References (19)

1. The world health organisation website viewed 11/10/05 http://www.who.int/mediacentre/factsheets/fs116/en/.
2. Desjeux P. Leishmaniasis-public health aspects and control. Clin Dermatol 14 5 (1996) 417-423
3. Herwaldt B. Leishmaniasis. The Lancet 354 (1999) 1191-1199
4. Henderson B., and Dougherty T. How does photodynamic therapy work?. Photochem Photobiol 55 1 (1992) 145-157
5. MacDonald I., and Dougherty T. Basic principles of photodynamic therapy. J Porphyrins Phthalocyanines 5 (2001) 105-129
6. Enk C.D., Fritsch C., Jonas F., et al. Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol 139 (2003) 432-434
7. Gardlo K., Horska Z., Enk C.D., et al. Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol 48 (2003) 893-896
8. Sah J.F., Ito H., Kolli B.K., Peterson D.A., Sassal S., and Chang K.-P. Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and for photodynamic therapy. J Biol Chem 277 (2002) 14902-14909
9. Kassab K., Amor T., Jori G., and Coppellotti O. Photosensitization of Colpdoda inflata cysts by meso-substituted cationic compounds. Photochem Photobiol Sci 1 (2002) 560-564
10. Kassab K., Dei D., Roncucci G., Jori G., and Coppellotti O. Phthalocyanine-photosensitized inactivation of a pathogenic protozoan, Acanthamoeba palestinensis. Photochem Photobiol Sci 2 (2003) 668-672
11. Merchat M., Spikes J., Bertoloni G., and Jori G. Studies on the mechanism of bacteria photosensitization by meso-substituted cationic compounds. J Photochem Photobiol B: Biol 35 (1996) 149-157
12. Segalla A., Boasarelli C., Braslavsky S., et al. Photophysical, photochemical and antibacterial photosensitizing properties of a novel octacationic Zn(II)-phthalocyanine. Photochem Photobiol Sci 1 (2002) 641-648
13. Hamblin M., O'Donnell D., Murthy N., Contag C., and Hasan T. Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol 75 (2002) 51-57
14. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother 42 (1998) 13-28
15. Hamblin M., and Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease?. Photochem Photobiol Sci 3 (2004) 436-450
16. Hudson R., Savoie H., and Boyle R.W. Lipophilic cationic compounds as photodynamic sensitisers, synthesis and structure-activity relationships. J Photodiagn Photodyn Therapy 2 3 (2005) 193-196
17. Obochi M., Boyle R., and van Lier J. Biological activities of phthalocyanines. XIII. The effects of human serum components on the in vitro uptake of and photodynamic activity of zinc phthalocyanine. Photochem Photobiol 37 (1993) 4
18. Deyes R. Cell viability assays. Promega Notes 81 (2002) 32-33
19. Dutta S., Ray D., Kolli B.K., and Chang K.-P. Photodynamic sensitisation of Leishmania amazonensis in both extracellular and intracellular stages with aluminium phthalocyanine chloride for photolysis in vitro. Antimicrob Agents Chemother 49 (2005) 4474-4484